Evidence map›Paper›PMID 40264146›Full record

ArticleMalaria journal2025

Decline in malaria test positivity rates following capacity building and archiving of malaria rapid diagnostic test cassettes in Oyo State, Nigeria: a retrospective review of records.

Esther Oluwayemisi Ayandipo, Motunrayo Fagbola, Adetomiwa Gbolade, Jay Thomas Okpokpolom, Abiodun Ojo, Olatayo Abikoye, IniAbasi Nglass, Olayemi Abimbola, Augustine Firima, Arja Huestis and 8 more

Abstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Esther Oluwayemisi AyandipoManagement Sciences for Health, Abuja, Nigeria. yayandipo@gmail.com.
Motunrayo FagbolaManagement Sciences for Health, Abuja, Nigeria.
Adetomiwa GboladeManagement Sciences for Health, Abuja, Nigeria.
Jay Thomas OkpokpolomManagement Sciences for Health, Abuja, Nigeria.
Abiodun OjoManagement Sciences for Health, Abuja, Nigeria.
Olatayo AbikoyeManagement Sciences for Health, Abuja, Nigeria.
IniAbasi NglassManagement Sciences for Health, Abuja, Nigeria.
Olayemi AbimbolaManagement Sciences for Health, Abuja, Nigeria.
Augustine FirimaManagement Sciences for Health, Abuja, Nigeria.
Arja HuestisManagement Sciences for Health, Abuja, Nigeria.
Gbolahan AbassOyo State Ministry of Health, Ibadan, Nigeria.
Babatunde OlatunjiOyo State Primary Healthcare Board, Ibadan, Nigeria.
Olufemi AdesanyaOyo State Hospital's Management Board, Ibadan, Nigeria.
Veronica MomohU.S. President's Malaria Initiative, USAID, Abuja, Nigeria.
Grace NwankwoU.S. President's Malaria Initiative, USAID, Abuja, Nigeria.
Erkwagh DagbaU.S. President's Malaria Initiative, USAID, Abuja, Nigeria.
Jules MihigoU.S. President's Malaria Initiative, USAID, Abuja, Nigeria.
Uchenna NwokennaManagement Sciences for Health, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe malaria test positivity rate (TPR) is a key indicator for evaluating the effectiveness of malaria interventions. In Nigeria, routine data from January to June 2021 reported consistently high TPRs, ranging from 73 to 82%, while Oyo State reported TPRs of 70% to 74% during the same period. These figures were inconsistent with malaria therapeutic efficacy studies conducted between October 2009 and November 2010, which reported a much lower TPR of 35%. This discrepancy raised concerns about data quality, increased malaria incidence, or inaccuracies in malaria diagnosis.

methodsThis study assessed the effect of two interventions aimed at improving the accuracy of TPR data using secondary quantitative data from the National District Health Information System (NDHIS) for both Primary Healthcare Facilities (PHFs) and Secondary Health Facilities (SHFs). The interventions included (1) facility-level audits of used malaria Rapid Diagnostic Test (RDT) cassettes archived at 733 PHFs, initiated in September 2021, and (2) a 10-day basic malaria microscopy training (BMMT) for Laboratory Scientists at 17 SHFs, completed in September 2021.

resultsAt PHFs, the RDT positivity rate declined from 71% in October 2021 to 53% in December 2022. A period review from January to September revealed a decrease in TPR from 62 to 53% in 2022, compared to no difference in TPR for the same period in 2021 with an average TPR of 77%. A paired t-test comparing the mean TPR for each period showed a statistically significant decline of 19.56 (t = 18.081, p < 0.01, CI (17.06-22.05). At SHFs, microscopy-based TPR decreased from 40% in October 2021 to 18% in December 2022. A review of January to September 2021 showed a TPR decline from 53 to 50%, while in 2022, TPR decreased from 25 to 18%. A paired t-test revealed a statistically significant decline of 19.33 in mean TPR at SHFs (t = 8.14, p < 0.01, CI 13.86-24.81).

conclusionThis study highlights the critical role of auditing used RDT cassettes and recommends scaling up this approach in PHFs. It also underscores the value of basic malaria microscopy training in improving the quality and accuracy of microscopy-based diagnosis. One limitation of this study is the absence of comparative data from other states in Nigeria where the interventions were not implemented.

Indexed as

Capacity BuildingDiagnostic Tests, RoutineMalariaHumansNigeriaRapid Diagnostic TestsRetrospective StudiesAuditCassette archivingDiagnosisHealth facilitiesMalaria RDTMicroscopyTest positivity rate

Identifiers

PMID40264146
PMCPMC12016084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.